Get Access to Trifluridine/Tipiracil in India

Trifluridine/Tipiracil also known by its name Lonsurf is recommended in the management of colorectal and gastric cancers. This is an FDA approved oral medication available as Lonsurf 15mg and Lonsurf 20mg tablets. This is indicated in patients with advanced stage cancer after priory chemotherapy and targeted therapy. Going by the published indications, Trifluridine/Tipiracil is used as a third or fourth line medication. The phase of cancer at this state would be metastatic stage. This drug helps is prolonging survival and offer better quality of life. Lonsurf in India is imported from European counties like Germany.

Trifluridine/Tipiracil is often referred as TAS-102, the technical name of the agent for research references. This medication was first approved for advanced colorectal cancer treatment in 2015. Later in 2019, it was granted the approval for Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma. Its EMA approval was given in 2016. Taiho Pharmaceuticals is credited for the development of this drug
which also was responsible for pursuing its regulatory approvals. The clinical data evidence is always the basis for such approvals. Anti cancer drugs often get the priority review to ensure early access of medication for the patients.

The growing relevance of using Trifluridine/Tipiracil in India is also attributed to the availability of high-end treatment options for the first and second lines of treatment. Chemotherapy and targeted therapies are effective in treating colorectal cancer and Lonsurf India option can be reserved for the later usage as and when necessary.